Wednesday, September 16, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document

Untitled source document

No live link available for this source.

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Low cost of generic medicines is a significant driver for demand, as their efficacy is at par with branded medicines

    60% confidence
  • The global Generic Drug Market will grow at a CAGR of approximately 6.55% during the forecast period from 2025 to 2034

    60% confidence
  • The global Generic Drug Market is expected to reach USD 519.11 Billion in 2025

    60% confidence
  • Asia Pacific is the second-largest market for generic medicines, driven by low disposable income and high chronic disease burden

    60% confidence
  • Oncology has emerged as the largest therapeutic application segment for generic medicines due to high global cancer prevalence

    60% confidence
  • Pure generic drugs experienced tremendous market growth due to high consumer demand and advanced manufacturing technologies

    60% confidence
  • North America is the largest regional market for generic drugs, driven by a large geriatric population with chronic diseases and the presence of key market players

    60% confidence
  • Expanding generic drug store presence in rural sectors represents a significant growth opportunity for the market

    60% confidence
  • Retail pharmacies are the largest distribution channel for generic drugs due to direct access to consumers

    60% confidence
  • Oral formulations are the leading route of administration for generic drugs and the most commonly used, including for children

    60% confidence
  • The global Generic Drug Market size was valued at approximately USD 491.35 Billion in 2024

    60% confidence
  • The global Generic Drug Market is projected to reach approximately USD 926.54 Billion by 2034

    60% confidence
  • Private medical practitioners preferring branded medicines due to higher profit margins is a key market restraint

    60% confidence
  • Lack of awareness about generic drug efficacy and absence of generic drug stores in rural areas are major market restraints

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI's 'Show-Me' Reckoning: Earnings Divergence, Executive Exodus, and Regulatory Tightening
Investors are shifting from rewarding AI narratives to demanding tangible results, evidenced by Adobe's weak guidance despite user-growth emphasis, Palantir's stock decline even after winning the Army's TITAN contract, and UiPath's contrasting guidance raise. Simultaneously, high-profile safety-driven departures from Anthropic and Google, plus new regulatory actions (California's under-16 social media ban, Anthropic's misuse-blocking disclosures), signal mounting scrutiny of AI's societal and financial risk profile even as fintech-adjacent funding (Socure) continues.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,288 source documents archived
Query this data → isubstrate.com